发明名称 |
SOLUBLE INTEGRIN A4 MUTANT |
摘要 |
The present invention addresses the problem of providing a novel substance capable of interfering with various functions of integrin ±4, and/or providing a novel substance capable of interfering with both integrin ±4 and integrin ±9. The present invention provides an integrin ±4 mutant peptide having one portion of the extracellular domain of human integrin ±4, and the like, and in concrete terms relates to a peptide and the like having the amino acid sequence of Sequence No. 4 through 9, and a pharmaceutical composition comprising as the active ingredient the same peptide. |
申请公布号 |
KR20140043795(A) |
申请公布日期 |
2014.04.10 |
申请号 |
KR20147001816 |
申请日期 |
2012.06.28 |
申请人 |
IMMUNO-BIOLOGICAL LABORATORIES CO., LTD.;GENE TECHNO SCIENCE CO., LTD. |
发明人 |
SEITO TSUTOMU;KON SHIGEYUKI |
分类号 |
C07K14/705;A61K38/17;C07K16/28 |
主分类号 |
C07K14/705 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|